HP661

N/A

Report date: 2023/05/10 09:04:09
NME

Base Information

Drug NameHP661
Drug Alias NameHP661HP-661
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNADH-ubiquinone oxidoreductase chain 1 inhibitors
TargetsNADH-ubiquinone oxidoreductase chain 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesEast China Normal UniversitySouthern Medical University, China
China Registration ClassN/A

Develop Information

Active CompaniesEast China Normal University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A